Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTAD GIA: Personalized Continuation Treatment for Adolescent Depression
NCT02017535Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Jun 2012
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in adolescent depression, sponsored by University of Minnesota. Started Jun 2012; status: completed.
02
Drugs
fluoxetine
03
Conditions
adolescent depression
Beyond the preview
Go deeper on NCT02017535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017535.